Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly
Ornella Corazza, Fabrizio Schifano, Magı́ Farré, Paolo Deluca, Zoe Davey, Colin Drummond, Marta Torrens, Zsolt Demetrovics, Lucia di Furia, Liv Flesland, Barbara Mervó, Jacek Moskalewicz, Agnieszka Pisarska, Harry L. Shapiro, Holger Siemann, Arvid Skutle, Cinzia Pezzolesi, Peer van der Kreeft, Norbert Scherbaum
Current reviews in clinical and experimental pharmacology May 1, 2011 DOI: 10.2174/157488411796151129 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Phenethylamines Hallucinogen The internet Psychoactive substance Internet privacy Designer drug Dragonfly Toxicology Pharmacology World wide web Ecology |
| Citations | 98 |
| Key findings | Online availability of information on Bromo-Dragonfly poses a public health challenge, requiring better international collaboration. |
Abstract
Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.
Citations in the library
Cited by 18
- Beyond THC: The New Generation of Cannabinoid Designer Drugs Frontiers in Behavioral Neuroscience 2011
- Novel psychoactive substances of interest for psychiatry World Psychiatry February 1, 2016
- 'Surfing the Silk Road': a study of users' experiences. International Journal of Drug Policy November 1, 2013
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Frontiers in Neuroscience April 19, 2016
- Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine Human Psychopharmacology: Clinical and Experimental March 1, 2012
and 13 more in the library
Cites 10
- Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Journal of Pharmacology and Experimental Therapeutics September 1, 1988
- Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research Pharmacopsychiatry July 1, 1998
- Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups Journal of Medicinal Chemistry 1996
- Enantiospecific Synthesis and Pharmacological Evaluation of a Series of Super-Potent, Conformationally Restricted 5-HT2A/2C Receptor Agonists Journal of Medicinal Chemistry January 26, 2001
- Psychoactive drug or mystical incense? Overview of the online available information on Spice products International Journal of Culture and Mental Health December 1, 2009
and 5 more in the library